Alexandria Real Estate Equities (ARE) › Analysis

Alexandria Real Estate Equities (ARE) stock analysis, November 3, 2026: Downtrend intact after big loss; rallies capped near $44

Published November 3, 2026 · updated 2026-11-11 · ARE chart, levels and live analysis

Update, November 11, 2026

Since the November 3 report, Alexandria Real Estate Equities (ARE) has edged up to $44.82, a modest 0.27% gain on the day but still down 2.57% over the past five days, lagging the S&P 500’s 0.74% decline in the same period as the REIT sector remains weak.

The picture holds – the daily close remains above the breakout trigger of $44.0, the stop at $45.49 and the key resistance at $45.0 (round) are untouched, and the weekly trend stays below the 40‑week SMA of $49.01. No weekly close has breached the SMA‑50 at $46.82, so the prior bearish, medium‑conviction outlook for the next 2‑6 weeks remains intact.

What would change the picture? A weekly close above the 200‑week SMA ($49.01) or a decisive move past the SMA‑50 resistance ($46.82) would force a reassessment. For the latest earnings details, see the SEC filing on October 26.

Alexandria Real Estate Equities (ARE) trades near $42 after a third-quarter net loss of $637.7 million, and the balance of evidence leans negative for the next 2 to 6 weeks. The stock sits below its 40-week average and 11.5% under its September 30 peak, with sellers showing up near $44 on rallies. Conviction is medium: the trend is clear, but the math for a further drop is thin.

Why it matters

The event was the quarterly report. On October 26, 2026, ARE filed its 10-Q for the period ending September 30, showing a net loss of $637.7 million, 174% larger than a year earlier, or $3.74 a share. The same day it filed an 8-K attaching its earnings supplemental. A loss of that size against a company worth about $7.3 billion is the kind of figure that forces investors to question how much of the asset base is worth what the books say.

What was already priced in is harder to pin down. The shares peaked at a $47.46 close on September 30 and are down 11.2% over the past month, so most of the slide came around and after the filing, not before it. The data here does not isolate the reaction on the day itself, and no commentary explains the move, so it would be a stretch to pin all of it on one number. What can be said is that the stock was already weak against the market: it trails the S&P 500 by 10.3% over 50 days and by 18.0% over 200 days, and it is down 14.1% year to date while SPY is up 10.5%.

The last five days complicate the picture. ARE gained 2.9% while SPY fell 2.1%, so the stock held up better than the market this week. No sector fund comparison is available, and no article in the feed explains the bounce. Today the shares slipped 1.3% on volume 56% below the 20-day average, a quiet move that says little in either direction.

No articles making the bull or bear argument were available for this note, so the debate has to be read from the numbers. The pessimistic side points to the loss, the downtrend and the weak showing against the market. The patient side points to valuation: 14 analysts have a consensus of hold, with a mean price target of $49.93, which is 15.9% above the current price. Their targets run from $37 to $60, a wide spread that shows how little agreement there is on what the assets are worth. The shares sit nearer the bottom of that range than the top.

What the evidence says

On the long term, the thesis is weakened and the stock is in a downtrend phase. Price is below both its 10-week and 40-week averages, and under the 50-day ($47.64) and 200-day ($49.39) averages. It is 29.6% below its 52-week high of $59.69 and only 5.3% above its low of $39.91. This is a stock that has not yet broken to new lows but has not shown any sign of recovery either.

For the next 2 to 6 weeks, the balance of evidence leans negative, with medium conviction (2 of 4 points). Two things support it: the daily trend runs with the weekly downtrend, so the two timeframes agree, and the stock has lagged the S&P 500 by 10.3% over 50 days. Those are the points scored. The other two are missing, and that is why conviction stops at medium.

The strongest case against this reading is the recent bounce and the neutral momentum. ARE is up 2.9% over five days while the market fell, and the 14-day RSI of 51.8 shows the stock is neither oversold nor stretched. The average analyst target is also well above the price. That does not tip the balance, because a five-day bounce has not reclaimed any average or the $44 zone, and a target above the price is not the same as buyers pushing it there. It is, though, the reason this is not a high-conviction reading.

Levels that matter

In a downtrend, the structure holds below $44.0, a zone where sellers have shown up on rallies. Above it sit $45.0 and then the 50-day average at $47.64, which is where the weekly trend would end. The 200-day average at $49.39 and a second swing zone at $49.02 stack up just above. Below the price, support is thin: $40.0 is the first round level, sitting just under the 52-week low of $39.91, and then $35.0.

The breakout level on the downside is a daily close below $40.0. From there the only target on the map is $35.0, and the move would be wrong if price climbed back above $44.45, which is $44.0 plus a quarter of the 14-day ATR of $1.80. That gives a reward-to-risk of 1.1 to 1, well short of the 3 to 1 that makes a breakout worth the risk. It would take a target far below $35 or a stop much closer to the $40 break to change that, and neither is on the map today.

What would change the picture

A weekly close above $47.64, the 50-day average, would be the first sign that buyers are back and the weekly downtrend is ending. The non-price fact that could do it is a quarterly report showing the loss shrinking sharply from the $3.74 a share reported for the third quarter, which would suggest the worst of the write-downs is behind the company. Without that, a price move above $44 alone would look like another rally into known selling.

What to watch

Get a message when the ARE picture changes — the agent team watches the levels and the news for you.Create a free account

More ARE analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.